Michael Wenger to Aged
This is a "connection" page, showing publications Michael Wenger has written about Aged.
Connection Strength
0.088
-
A measure for assessing the effects of audiovisual speech integration. Behav Res Methods. 2014 Jun; 46(2):406-15.
Score: 0.056
-
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS). Lancet Haematol. 2019 May; 6(5):e254-e265.
Score: 0.019
-
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014 Mar 20; 370(12):1101-10.
Score: 0.014